Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	62.79	67.13	119.17	16.64	68.14	103.11
Short-Term Investments	14.39	13.35	-	-	-	-
Cash & Short-Term Investments	77.18	80.48	119.17	16.64	68.14	103.11
Cash Growth	-20.91%	-32.46%	616.23%	-75.58%	-33.92%	7508.91%
Other Receivables	-	-	-	-	0.34	0.04
Receivables	-	-	-	-	0.34	0.04
Prepaid Expenses	1.76	1.59	1.51	0.8	0.2	0.12
Other Current Assets	-	-	-	0.07	2.33	0.85
Total Current Assets	78.93	82.08	120.67	17.51	71	104.12
Property, Plant & Equipment	1.59	1.81	2.26	2.77	3.08	3.59
Long-Term Deferred Charges	-	-	-	0.71	0.47	0.53
Other Long-Term Assets	0.41	0.45	0.73	0.1	0.1	0.05
Total Assets	80.93	84.34	123.65	21.09	74.64	108.28
Accounts Payable	1.83	0.65	1.55	2.47	2.76	0.84
Accrued Expenses	8.42	8.81	2.24	0.8	1.33	1.56
Short-Term Debt	0.66	-	-	0.11	-	-
Current Portion of Leases	0.6	0.56	0.55	0.49	0.43	0.37
Current Unearned Revenue	2.14	2.59	0.79	0.71	1.24	1.42
Total Current Liabilities	13.64	12.61	5.12	4.57	5.77	4.19
Long-Term Leases	0.61	0.95	1.57	2.12	2.61	3.35
Long-Term Unearned Revenue	0.34	0.39	2.67	2.32	1.56	2.49
Total Liabilities	14.59	13.95	9.37	9.01	9.93	10.03
Common Stock	0.04	0.03	0.03	0.01	0.01	0.18
Additional Paid-In Capital	512.4	481.96	474.44	342.89	336.28	315.6
Retained Earnings	-442.14	-407.63	-356.21	-326.85	-267.6	-219.84
Treasury Stock	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97
Comprehensive Income & Other	0.01	0.01	-	-	-	-
Total Common Equity	66.34	70.39	114.29	12.08	64.72	91.97
Shareholders' Equity	66.34	70.39	114.29	12.08	64.72	98.25
Total Liabilities & Equity	80.93	84.34	123.65	21.09	74.64	108.28
Total Debt	1.87	1.51	2.12	2.71	3.04	3.72
Net Cash (Debt)	75.31	78.97	117.05	13.93	65.1	99.39
Net Cash Growth	-21.38%	-32.53%	740.43%	-78.61%	-34.50%	-
Net Cash Per Share	2.32	2.56	6.05	2.00	9.86	34.62
Filing Date Shares Outstanding	39.5	29.16	27.03	7.87	6.89	6.38
Total Common Shares Outstanding	38.89	29	27.03	7.31	6.88	6.02
Working Capital	65.29	69.46	115.55	12.93	65.23	99.93
Book Value Per Share	1.71	2.43	4.23	1.65	9.40	15.28
Tangible Book Value	66.34	70.39	114.29	12.08	64.72	91.97
Tangible Book Value Per Share	1.71	2.43	4.23	1.65	9.40	15.28
Machinery	-	1.6	1.48	1.49	1.45	1.29
Leasehold Improvements	-	0.22	0.21	0.21	0.21	0.21

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q